Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Jubilant HollisterStier | Contract Pharma
Breaking News, Promotions & Moves

Jubilant HollisterStier

David A. Linn has been named director of business intelligence and business development for Jubilant HollisterStier’s Contract Manufacturing & Services Division.

David A. Linn has been named director of business intelligence and business development for Jubilant HollisterStier’s Contract Manufacturing & Services Division.

Mr. Linn joins the company from DSM Pharmaceuticals, where he served in various marketing and sales positions during the past 10 years. Most recently, he was senior director of marketing and business development responsible for advertising, promotion and market intelligence activities for DSM’s Finished Dosage Form business. He also has more than seven years of experience at DSM in account management, and was the global project manager for two corporate-level teams focused on business process improvement and CRM implementation. Prior to DSM, Mr. Linn was a project manager at Bausch & Lomb Pharmaceuticals.

“I am excited to have David join our team and look forward using his insight and industry experience to help us expand Jubilant HollisterStier’s contract manufacturing reach,” said Curtis Gingles, vice president of marketing and sales, Jubilant HollisterStier.@font-face { font-family: “Cambria”; }@font-face { font-family: “Optima”; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: “Times New Roman”; }div.Section1 { page: Section1; }

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters